Clinical Trial

GA101 clinical trail press release…

Posted on 9 December 2013 by Paul Brennan

There was a nice story on the BBC today about GA101, a new antibody targeting CD20 which is being used to treat CLL. Our own, Professor Chris Fegan gave quotes for the BBC article. The press release follows very promising results showing that GA101 works better than┬áMabThera/Rituxan as reported in last summer’s press release from
Read more


Promising clinical results for new drug for CLL

Posted on 17 May 2013 by Stephen Man

Professor Chris Fegan featured in the media, after the announcement of promising results from a clinical trial of obinutuzumab (GA101) conducted in Cardiff. Click on the picture to watch the video interview with Chris (this can also be found at http://www.itv.com/news/wales/topic/cardiff/) More details on the story can be found below: http://www.express.co.uk/news/uk/400000/Drug-hope-for-leukaemia-sufferers http://www.cardiffandvaleuhb.wales.nhs.uk/news/27256
Read more